Pancreatic Cancer Research Program

Sponsor Deadline: 

Oct 5, 2023

Letter of Intent Deadline: 

Jul 10, 2023


Department of Defense/CDMRP

UI Contact: 

Idea Development Award
Funding Opportunity Number: HT9425-23-PCARP-IDA
The PCARP Idea Development Award supports the development of innovative, high-risk/highreward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation

Translational Research Partnership Award
Funding Opportunity Number: HT9425-23-PCARP-TRPA
The FY23 PCARP Translational Research Partnership Award supports partnerships between clinicians and research scientists that will accelerate the movement of promising ideas in pancreatic cancer toward clinical applications. This award supports the development of translational research collaborations between two independent investigators to address a central problem or question in pancreatic cancer in a manner that would be less readily achievable through separate efforts.

One partner in the collaboration must function as a research scientist and the other partner as a clinician investigator. It should be clear that both have had equal intellectual input in the design of the research project. Projects involving convergence science partnerships are strongly encouraged. At least one partner must have expertise either in pancreatic cancer research or pancreatic cancer patient care. Inclusion of experts from outside the pancreatic cancer field is encouraged. A proposed project in which the clinical partner merely supplies tissue samples or access to patients will not meet the intent of this award mechanism. Full support for large-scale clinical trials is not expected; retrospective tissue analysis, correlative studies, or small pilot clinical trials are permitted.

See more details about these awards